US FDA registration completed in the United States and TGA approval obtained in Australia...
Partnership aims to reduce childhood malnutrition and promote healthy habits for future generations...
GALI™ SonR® CRT-D and NAVIGO™ 4LV Pacing Leads Launch Set to Enhance Heart Failure Management and Patient Safety...
$25 million investment to meet growing global demand for medical devices and precision components...
Invitation Extended for MEDICAL JAPAN TOKYO, Promising Larger Edition and Expanded Networking Opportunities...
Collaborative Milestones: Department of Health – Abu Dhabi Teams Up with Masdar City, Xlife Sciences, and Thermo Fisher Scientific...
Jiva.ai and Aevice Health collaborate to pioneer breakthrough medical AI for asthma adverse event prediction based on Aevice Health’s FDA-cleared remote patient monitor....
New joint venture creates pathway for introducing UltraSight's technology to Korean market...
MicroPort EverPace's latest generation Columbus™ 3D EP Navigation System (Columbus™) has recently received CE MDR approval....
Terumo India, the Indian arm of Japan-based medtech firm Terumo Corporation, has recently announced the launch of new medical tools, intended for use in the management of liver cancer. With World Cancer Day, on February 4, 2024, calling to improve prevention, detection and treatment of cancer, new products are being launched in the Indian market to shape a way forward. MedTech Spectrum & BioSpectrum India spoke to Shishir Agarwal, President and Managing Director, Terumo India about the current s...
![[L-R]: Ms. Vivien Tan, XP Business Manager, Siemens Healthineers ASEAN; Prof. Dr. dr. Lina Choridah, Sp.Rad (K), Chairwoman Indonesian Woman Imaging Society; Hendya Perbangkara, Head of Diagnostic Imaging, Siemens Healthineers Indonesia](/uploads/articles/l_r__ms_vivien_tan_xp_business_manager_siemens_healthineers_asean-24188.jpg)
